Vinayak Doraiswamy, Chief Scientific Officer at AtriCure, Inc. (ATRC), sold 15,344 shares at $83.12 ($1.3M) on 2021-07-12, disclosed to the SEC on 2021-07-14.
Open-market sale of $1.3M ATRC by Chief Scientific Officer. Not flagged as scheduled, tax-driven, or recurring — but no specific bearish signal from our filters. Reasons for insider sales vary widely.
Nothing distinguishes this filing.
| # | Price | Shares | Value | % of Total |
|---|---|---|---|---|
| 1 | $83.12 | 7,672 | $638K | 50.0% |
| 2 | $83.12 | 7,672 | $638K | 50.0% |
| Total | $83.12 avg | 15,344 | $1.3M | 100% |
| Filing → |
| ATRC | SELL | 2026-03-16 | $149K | — | Filing → |
| ATRC | SELL | 2025-08-07 | $91K | — | Filing → |
| ATRC | SELL | 2025-05-30 | $84K | — | Filing → |